thalidomide has been researched along with Carcinoma, Papillary in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizutani, S | 1 |
| Kuroda, J | 1 |
| Sasaki, N | 1 |
| Kiyota, M | 1 |
| Tatekawa, S | 1 |
| Tsukamoto, T | 1 |
| Maegawa, S | 1 |
| Chinen, Y | 1 |
| Shimura, Y | 1 |
| Nagoshi, H | 1 |
| Kobayashi, T | 1 |
| Horiike, S | 1 |
| Tando, S | 1 |
| Fushiki, S | 1 |
| Taniwaki, M | 1 |
| Abramson, N | 1 |
| Stokes, PK | 1 |
| Luke, M | 1 |
| Marks, AR | 1 |
| Harris, JM | 1 |
1 trial available for thalidomide and Carcinoma, Papillary
| Article | Year |
|---|---|
Ovarian and papillary-serous peritoneal carcinoma: pilot study with thalidomide.
Topics: Adult; Aged; Angiogenesis Inhibitors; CA-125 Antigen; Carcinoma, Papillary; Cystadenocarcinoma, Sero | 2002 |
1 other study available for thalidomide and Carcinoma, Papillary
| Article | Year |
|---|---|
Quadruple Cancers of Non-producing Multiple Myeloma, Cholangiocellular Carcinoma, and Two Different Thyroid Cancers.
Topics: Aged; Bile Duct Neoplasms; Bortezomib; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; C | 2016 |